CaAKG Reverses Alzheimer's Synaptic Deficits in Mice via Autophagy Boost
Calcium alpha-ketoglutarate rescues memory-related synaptic plasticity in Alzheimer's mice, pointing to a geroprotective supplement as a potential AD therapy.
Summary
Researchers at the National University of Singapore tested calcium alpha-ketoglutarate (CaAKG) — a TCA-cycle metabolite already linked to lifespan extension — in APP/PS1 Alzheimer's mice. CaAKG restored long-term potentiation (LTP) at hippocampal CA1 synapses, with stronger effects in females than males. The rescue worked through an NMDA-receptor-independent pathway involving L-type calcium channels and calcium-permeable AMPA receptors. CaAKG also elevated LC3-II, a marker of autophagy, and facilitated synaptic tagging and capture — a cellular model of associative memory. Rapamycin, an mTOR inhibitor, mirrored these effects in AD mice but paradoxically blocked LTP in wild-type animals, suggesting the autophagy pathway is particularly important when synaptic function is already compromised.
Detailed Summary
Alzheimer's disease (AD) progressively destroys memory, and while amyloid plaques and tau tangles are its hallmarks, synaptic dysfunction tracks more closely with cognitive decline. Finding compounds that restore synaptic plasticity — especially ones already tolerated in aging research — is a priority. Alpha-ketoglutarate (AKG), a central metabolite of the tricarboxylic acid (TCA) cycle, extends lifespan across yeast, worms, flies, and mice, and its calcium salt form (CaAKG) offers superior bioavailability and sustained release. This study is the first to interrogate CaAKG's neuroprotective potential directly at the synapse in an AD mouse model.
Using 4–5 month-old APP/PS1 transgenic mice — an early-onset familial AD model that already shows impaired LTP, amyloid burden, and microglial activation at this age — the team performed acute hippocampal slice electrophysiology. Bath application of CaAKG (or AKG) for 60 minutes around strong tetanic stimulation (STET) rescued LTP at Schaffer collateral–CA1 synapses in both male and female AD mice, while untreated AD slices showed characteristically deficient potentiation. Notably, the rescue was significantly more robust in female AD mice than in males, a sex difference that warrants further mechanistic investigation.
To dissect the mechanism, the authors applied pharmacological blockers. CaAKG-rescued LTP persisted even when NMDA receptors were blocked with AP5, ruling out the canonical NMDAR-dependent induction pathway. Instead, blockade of L-type voltage-gated calcium channels (LTCC) with nifedipine, or of calcium-permeable AMPA receptors (CP-AMPARs) with IEM-1460, abolished the CaAKG effect. This NMDAR-independent, LTCC/CP-AMPAR-dependent mechanism suggests CaAKG recruits an alternative calcium-entry route to drive synaptic strengthening — one that may remain functional even when NMDAR signaling is disrupted by amyloid oligomers.
Western blot analysis of hippocampal slices revealed that CaAKG significantly elevated LC3-II levels in APP/PS1 tissue, indicating enhanced autophagy flux. Consistent with this, rapamycin — an mTOR inhibitor that promotes autophagy — also rescued LTP in AD slices. Strikingly, rapamycin blocked LTP in wild-type slices, implying that excessive autophagy induction is detrimental to already-healthy synapses, but beneficial when synaptic machinery is overburdened by pathological protein aggregates. This differential effect strengthens the argument that autophagy enhancement is a key component of CaAKG's neuroprotective action in AD.
Finally, CaAKG facilitated synaptic tagging and capture (STC) in AD mice — a two-pathway associative plasticity paradigm where a weak stimulus at one synapse gains long-term strength by capturing plasticity-related proteins synthesized at a nearby strongly stimulated synapse. STC is considered an in vitro model for associative memory consolidation and is particularly sensitive to early neurodegeneration. Restoration of STC by CaAKG suggests the compound may support not just individual synapse strengthening but the network-level associative processes underlying episodic memory.
Key Findings
- CaAKG restored LTP at hippocampal CA1 synapses in APP/PS1 AD mice, with stronger rescue in females than males.
- The mechanism was NMDA receptor-independent, instead requiring L-type calcium channels and CP-AMPARs.
- CaAKG elevated LC3-II autophagy markers in AD hippocampal slices; rapamycin replicated the LTP rescue.
- Rapamycin blocked LTP in wild-type mice but rescued it in AD mice, revealing a disease-specific autophagy benefit.
- CaAKG restored synaptic tagging and capture in AD mice, suggesting it can support associative memory processes.
Methodology
Acute hippocampal slices (400 µm) from 4–5 month-old APP/PS1 and wild-type mice (51 and 52 animals, respectively; ~200 slices total) were used for field electrophysiology at CA1 Schaffer collateral synapses in a two-pathway design. CaAKG or AKG was bath-applied for 60 minutes centered on strong tetanic stimulation (STET); pharmacological blockers (AP5, nifedipine, IEM-1460) and rapamycin were used to dissect mechanisms. Western blotting for LC3-II (autophagy marker) was performed on snap-frozen post-recording slices.
Study Limitations
The study used only acute ex vivo slice electrophysiology; no in vivo cognitive behavioral testing (e.g., Morris water maze) was performed in this paper to confirm memory improvement. All mice were tested at 4–5 months (early-stage pathology), so effects at later, more advanced AD stages are unknown. The sex difference in response magnitude was observed but not mechanistically explained, and the study did not assess long-term dietary CaAKG supplementation effects on synaptic plasticity.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.